RSS   Newsletter   Contact   Advertise with us
Post Online Media

Teva expects Q4 revenues to be $6.2-$6.5 billion

Teva
Teva   Non-GAAP EPS is expected to be $1.34-$1.44

Teva reaffirmed its full-year 2016 outlook: revenues for full year 2016 are expected to be $21.6-$21.9 billion and revenues for the fourth quarter of year 2016 are expected to be $6.2-$6.5 billion.


Non-GAAP EPS for 2016 is expected to be $5.10-$5.20, based on a weighted average number of shares of 1,020 million.

Non-GAAP EPS is expected to be $1.34-$1.44, based on a weighted average number of shares of 1,077 million.

Cash flow from operating activities for 2016 is expected to be $4.8-$5.0 billion; cash flow from operating activities for the fourth quarter of 2016 is expected to be $1.0-$1.2 billion.

 

What to read next

 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.